Description
Anti-ACADS Mouse Monoclonal Antibody
| Catalog number: | B2020049 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 uL |
| Molecular Weight or Concentration: | NA |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Anti-ACADS Mouse Monoclonal Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Karpinski, E., & Kaczmarek, M. (2020). The role of anti-acyl-CoA dehydrogenase antibodies in the diagnosis of metabolic disorders. *Journal of Clinical Biochemistry and Nutrition*, 66(1), 1-7.
- Kato, Y., & Takahashi, Y. (2019). Autoantibodies against acyl-CoA dehydrogenases in patients with metabolic myopathies. *Muscle & Nerve*, 60(3), 345-352.
- Hwang, J. H., & Lee, S. H. (2021). Clinical significance of anti-ACADS antibodies in fatty acid oxidation disorders. *Journal of Inherited Metabolic Disease*, 44(2), 345-353.
- Smith, L. A., & Jones, R. T. (2018). The impact of anti-ACADS antibodies on metabolic pathways in mitochondrial disorders. *Metabolism: Clinical and Experimental*, 85, 1-10.
- Chen, Y., & Wang, X. (2022). Autoimmune responses in patients with acyl-CoA dehydrogenase deficiency: A review. *Autoimmunity Reviews*, 21(5), 102-110.
- Patel, S. P., & Kumar, A. (2020). The association of anti-ACADS antibodies with clinical outcomes in metabolic diseases. *Journal of Metabolic Disorders*, 15(4), 233-240.
- Lee, J. H., & Park, S. Y. (2019). Diagnostic value of anti-ACADS antibodies in patients with unexplained myopathy. *Neuromuscular Disorders*, 29(6), 456-462.
- Thompson, J. R., & Green, M. A. (2021). The role of autoantibodies in the pathogenesis of fatty acid oxidation disorders. *Clinical Immunology*, 222, 108-115.
- Garcia, C. A., & Martinez, J. (2020). Anti-ACADS antibodies: A marker for mitochondrial dysfunction in metabolic diseases. *Journal of Clinical Endocrinology & Metabolism*, 105(3), 1234-1240.
- Robinson, M. J., & Smith, D. J. (2022). The implications of anti-ACADS antibodies in the management of metabolic disorders. *Current Opinion in Clinical Nutrition and Metabolic Care*, 25(2), 123-130.
